IP Library Granted Patent US 10,085,981
Granted Patent B2
US 10,085,981 · App. 15/744,399 · Granted Oct 2, 2018

Protein acyl transferase inhibitors and methods of treatment

Inventors: Robert Joseph Deschenes (Tampa, FL); Marcello Angelo Giulianotti (Vero Beach, FL); Richard Allen Houghten (Port St. Lucie, FL); David Allen Mitchell (Lutz, FL); Laura Dawn Hamel (Temple Terrace, FL)
Assignees: University of South Florida; Torrey Pines Institute for Molecular Studies
A61K31/496A61P35/02
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,085,981
App. No.
15/744,399
Granted
Oct 2, 2018
Kind
B2
Abstract

Embodiments of the present disclosure include compositions and pharmaceutical compositions that include protein acyl transferases (PAT) inhibitors, methods of treating a condition or disease, methods of treating autopalmitoylation activity, and the like.

Claims (42)

1. A composition, comprising: a compound having the following structure:

wherein each of R1, R2, and R3 is independently selected from the group consisting of:

and

2. The composition of claim 1 , wherein each of R1, R2, and R3 is independently selected from the group consisting of:

3. The composition of claim 1 , wherein R1 is

R2 is

and R3 is

4. The composition of claim 1 , wherein R1 is

R2 is

and R3 is

5. The composition of claim 1 , wherein R1 is

R2 is

and R3 is

6. A pharmaceutical composition comprising a therapeutically effective amount of a compound or a pharmaceutically acceptable salt of the compound, and a pharmaceutically acceptable carrier, to treat a condition, wherein the compound has the following structure:

wherein each of R1, R2, and R3 is independently selected from the group consisting of:

and

7. The pharmaceutical composition of claim 6 , wherein the condition is a disease selected from the group consisting of: colorectal cancer, leukemia, and cervical cancer.

8. The pharmaceutical composition of claim 7 , wherein each of R1, R2, and R3 is independently selected from the group consisting of:

and,

9. The pharmaceutical composition of claim 7 , wherein R1 is

R2 is

and R3 is

10. The pharmaceutical composition of claim 7 , wherein R1 is

R2 is

and R3 is

11. The pharmaceutical composition of claim 7 , wherein R1 is

R2 is

and R3 is

12. A method of treating autopalmitoylation activity, comprising: delivering to a subject in need thereof, a pharmaceutical composition, wherein the pharmaceutical composition includes a therapeutically effective amount of a compound, or a pharmaceutically acceptable salt of the compound, and a pharmaceutically acceptable carrier, wherein the compound has the following structure:

wherein each of R1, R2, and R3 is independently selected from the group consisting of:

and

13. The method of claim 12 , wherein each of R1, R2, and R3 is independently selected from the group consisting of:

and,

14. The method of claim 12 , wherein R1 is

R2 is

and R3 is

15. The method of claim 12 , wherein R1 is

R2 is

and R3 is

16. The method of claim 12 , wherein R1 is

R2 is

and R3 is

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 7, 2018
From: DESCHENES, ROBERT JOSEPH; MITCHELL, DAVID ALLEN; HAMEL, LAURA DAWN
To: UNIVERSITY OF SOUTH FLORIDA
Reel/Frame 045730/0097 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 14, 2018
From: GIULIANOTTI, MARCELLO ANGELO; HOUGHTEN, RICHARD ALLEN
To: TORREY PINES INSTITUTE FOR MOLECULAR STUDIES
Reel/Frame 044928/0239 →
CONFIRMATORY LICENSE Recorded Feb 13, 2018
From: UNIVERSITY OF SOUTH FLORIDA
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 045310/0054 →
Continuity (2)
Provisional Application 62191656 · Jul 13, 2015
Related Publication 20180200250A1 · Jul 19, 2018